×
NexGel EBITDA 2021-2024 | NXGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
NexGel ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
NexGel EBITDA 2021-2024 | NXGL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
NexGel ebitda from 2021 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$233.5B
Intuitive Surgical (ISRG)
$174.1B
Alcon (ALC)
$48.6B
IQVIA Holdings (IQV)
$43.5B
Edwards Lifesciences (EW)
$41.3B
IDEXX Laboratories (IDXX)
$41.2B
DexCom (DXCM)
$27.9B
STERIS (STE)
$24.1B
SONOVA HOLDING (SONVY)
$21.4B
Waters (WAT)
$19.3B
Hologic (HOLX)
$18.8B
Fresenius Medical Care AG KGaA (FMS)
$12.4B
Sysmex ADR (SSMXY)
$12.4B
Teleflex (TFX)
$11.6B
Globus Medical (GMED)
$9.4B
Penumbra (PEN)
$7.3B
Glaukos (GKOS)
$6.9B
Masimo (MASI)
$6B
TransMedics (TMDX)
$5.1B
Integer Holdings (ITGR)
$4.3B
PROCEPT BioRobotics (PRCT)
$4.2B
Tandem Diabetes Care (TNDM)
$2.9B
Inari Medical (NARI)
$2.7B
LivaNova (LIVN)
$2.6B
Veracyte (VCYT)
$2.5B
Nihon Kohden (NHNKY)
$2.5B
Elekta AB (EKTAY)
$2.5B
RxSight (RXST)
$2B
Integra LifeSciences Holdings (IART)
$1.4B
Pulse Biosciences (PLSE)
$1.1B